Periocular hyaluronic acid fillers
Authors:
- 1 September 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Ophthalmology
- Vol. 30 (5) , 395-400
Abstract
The use of dermal filler in the periocular area is increasing – both for functional and aesthetic indications. Hyaluronic acid fillers dominate the market; these treatments offer an alternative to some surgical procedures with the advantage of instant results, minimal healing time and low complication rates. However, success depends on judicious selection of patients, products and procedures to achieve favourable outcomes. This article reviews current understanding of the principal complications in the periocular area and their management. Hyaluronic acid is a ubiquitous, biodegradable, nonspecies-specific molecular substrate with limited potential for immunogenic reactions. However, in the periocular area, such products can migrate and last significantly longer than the expected filler lifespan. Contamination or subsequent immune stimulation can trigger delayed-onset inflammatory reactions. Though minor vascular occlusions are not uncommon, cases of blindness secondary to facial filler injections are thought to be rare. Timely enzymatic degradation with injectable hyaluronidase can be effective in the treatment of some such complications. But recent studies demonstrate lack of penetration through arterial walls and optic nerve sheath, casting doubt on the role of retrobulbar hyaluronidase in the management of vision loss because of embolism with hyaluronic acid filler. Hyaluronic acid fillers represent an emerging and important addition to the armamentarium of the oculofacial plastic surgeon with their use in the aesthetic field also expected continue to rise. The oculoplastic facial surgeon, armed with a thorough knowledge of facial anatomy, safe injection planes and the means of minimizing and treating complications is in the best position to lead clinically in the use of this well tolerated and effective treatment modality.Keywords
This publication has 37 references indexed in Scilit:
- Iatrogenic Occlusion of the Ophthalmic Artery After Cosmetic Facial Filler InjectionsJAMA Ophthalmology, 2014
- A Review of the Metabolism of 1,4-Butanediol Diglycidyl Ether-Crosslinked Hyaluronic Acid Dermal FillersDermatologic Surgery, 2013
- Complications of Injectable Fillers, Part IAesthetic Surgery Journal, 2013
- Contemporary Review of Injectable Facial FillersJAMA Facial Plastic Surgery, 2013
- Etiology, Prevention, and Treatment of Dermal Filler ComplicationsAesthetic Surgery Journal, 2011
- Adjunctive Use of Hyaluronic Acid Gel (Restylane Sub-Q) in Anophthalmic Volume Deficient Sockets and Phthisical EyesOphthalmic Plastic & Reconstructive Surgery, 2010
- Complications of Hyaluronic Acid FillersFacial Plastic Surgery, 2009
- Supporting evidence-based infection prevention and control practice in the National Health Service in England. The NHS/TVU/Intuition ApproachJournal of Hospital Infection, 2007
- Filling the Periorbital Hollows With Hyaluronic Acid Gel: Initial Experience With 244 InjectionsOphthalmic Plastic & Reconstructive Surgery, 2006
- Adverse reactions to dermal fillers: A review of European experiencesJournal of Cosmetic and Laser Therapy, 2005